Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C

被引：18

作者：

Strickland, GT ^{[1
]}

Tanamly, MD

Tadros, F

Labeeb, S

Makld, H

Nessim, D

Mikhail, N

Magder, LS

Afdhal, NH

Medhat, A

Abdel-Hamid, M

机构：

[1] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA

[2] Assiut Univ, Fac Med, Assiut, Egypt

[3] Assiut Univ, Fac Nursing, Assiut, Egypt

[4] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt

[5] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

来源：

DIGESTIVE AND LIVER DISEASE | 2005年 / 37卷 / 07期

关键词：

D O I：

10.1016/j.dld.2005.03.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：542 / 543

页数：2

共 4 条

[1] Milk thistle (Silybum marianum) for the therapy of liver disease [J].

Flora, K ;

Hahn, M ;

Rosen, H ;

Benner, K .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143

[2] Milk thistle for the treatment of liver disease: A systematic review and meta-analysis [J].

Jacobs, BP ;

Dennehy, C ;

Ramirez, G ;

Sapp, J ;

Lawrence, VA .

AMERICAN JOURNAL OF MEDICINE, 2002, 113 (06) :506-515

[3] Herbal products for liver diseases: A therapeutic challenge for the new millennium [J].

Schuppan, D ;

Jia, JD ;

Brinkhaus, B ;

Hahn, EG .

HEPATOLOGY, 1999, 30 (04) :1099-1104

[4] Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results [J].

Tanamly, MD ;

Tadros, F ;

Labeeb, S ;

Makld, H ;

Shehata, M ;

Mikhail, N ;

Abdel-Hamid, M ;

Shehata, M ;

Abu-Baki, L ;

Medhat, A ;

Magder, LS ;

Afdhal, NH ;

Strickland, GT .

DIGESTIVE AND LIVER DISEASE, 2004, 36 (11) :752-759

← 1 →